久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Novo Nordisk launches innovative insulin product in China

By Zhou Wenting | chinadaily.com.cn | Updated: 2019-12-07 16:21
Share
Share - WeChat
Novo Nordisk's products. [Photo provided to chinadaily.com.cn]

The world's first insulin product working for both a stable blood glucose level around the clock and a healthy postprandial blood glucose level was launched in the Chinese market in Shanghai on Saturday.

The innovative injection by Denmark's biopharmaceutical company Novo Nordisk that had been previously available in 29 countries and regions overseas after making its world market debut in 2012 was claimed to be "very suitable" for Chinese diabetes patients, who have a high need for controlling the postprandial blood glucose level as they take high-carbohydrate meals with a relatively high glycemic index.

Ji Linong, a leading medical expert in diabetes in China, said that it is probably so far the best insulin product that simulates the physiological secretion of insulin in the human body.

"Some current insulin injections may pose a threat to causing low blood glucose for patients, and such concerns may lead to some patients randomly reducing their amount of medicine use, which impairs the long-term control of blood glucose within a reasonable range," said Ji, who is also director of the endocrinology department at Peking University People's Hospital in Beijing.

Data from the International Diabetes Foundation showed that the incidence rate of the disease kept climbing up over the past three decades and reached 10.9 percent in China in 2017.

"Compared to their counterparts in Western countries, Chinese diabetes patients suffer more often from the abnormal rise of postprandial blood glucose, triggering fluctuation of blood glucose levels over 24 hours, which may often result in cardiovascular diseases, and can be fatal in serious cases," said Mu Yiming, director of the endocrinology department at the Beijing-based General Hospital of the Chinese People's Liberation Army.

The new insulin product, which requires only one injection a day, is composed of two types of insulin that can work independently from each other to respectively control blood glucose levels for 24 hours and longer and after meals, the company said.

At least 10 innovative drugs treating various chronic diseases are scheduled to be introduced to the Chinese market in the upcoming five years to better contribute to the Healthy China 2030 Initiative, the company said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 最新亚洲精品国自产在线 | 在线久草视频 | 扒开双腿猛进入爽爽在线观看 | 波多野结衣在线观看一区 | 久久好看视频 | 欧美一级精品高清在线观看 | 国产视频二区 | 欧美日韩看看2015永久免费 | 国产精品人伦久久 | 在线观看一区二区三区视频 | 三a毛片 | 国产精品拍拍拍福利在线观看 | 国产高清美女一级毛片久久 | 久久黄色影片 | 国产精品高清全国免费观看 | 免费a级毛片大学生免费观看 | 一级毛片在线视频 | 国产精品三级 | 色内内免费视频播放 | 日本国产一区二区三区 | 在线欧美精品一区二区三区 | 国产成人精品久久综合 | 精品国产成人a区在线观看 精品国产成人a在线观看 | 真人一级毛片免费完整视 | 99在线小视频 | 波多野结衣3女同在线观看 波多野结衣aⅴ在线 | 日韩欧美中文字幕在线播放 | 欧美日韩在线视频 | 明星国产欧美日韩在线观看 | 久草在线视频中文 | 成年女人黄小视频 | 岛国午夜精品视频在线观看 | 亚洲精品一区二区三区不卡 | 国产精品一久久香蕉国产线看 | 国产精品久久久久久久 | 日本高清在线精品一区二区三区 | 国产香蕉在线视频一级毛片 | 日本一区毛片免费观看 | 精品一区二区三区高清免费不卡 | 精品手机在线 | 国产视频自拍偷拍 |